PolarityTE (NASDAQ:PTE) subsidiary, Arches Research has entered into a strategic partnership with Co-Diagnostics (NASDAQ:CODX) to expand COVID-19 testing operations.
Under the agreement, Arches will provide COVID-19 testing for customers referred by Co-Diagnostics and, to support additional demand, latter will provide testing equipment in exchange for commitment to use only Co-Diagnostics’ tests on the equipment.
Arches has previously been performing COVID-19 testing using CODX’s Logix Smart COVID-19 test kit.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.